))
Birth, Life & Death. It All Comes Down To Age Management ft. Ian White, M.S., Ph.D.
Manage episode 390042133 series 3538698
İçerik Rusty Humphries and Mark L. White tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Rusty Humphries and Mark L. White veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Most people are not aware that we all experience a huge metabolic switch between the ages of 15-25 that shifts our bodies from growth and into aging. Although experts have not been able to identify the cause behind this switch, leaders in the field of regenerative medicine, like Dr. Ian White, are on a mission to discover it with the goal of ending aging forever.
During this fascinating episode, Dr. White and I cover the topics below: - The science of aging and age-related disease - Why we age and why we don’t have to - The Unified Theory of LIFE: Evolution, aging and the future of regenerative medicine - Editing genes to rid disease - Billionaires & Mars: What's going to happen to the rest of us?
*About Our Guest* Dr. White is an expert in the field of regenerative medicine and stem cell biology with over 20 years experience working in academia and industry. Dr. White received his B.S. from Liverpool John Moores University and his M.S. from the famed Liverpool School of Tropical Medicine in England before being hired at Dartmouth College in the United States to study the genetics of gamete biology. In August of 2000 Dr. White was recruited to Harvard University to work with hematopoietic stem cells (HSCs) and immune cell biology under the mentorship of the world-renowned Dr. Laurie Glimcher, where he co-authored several peer-reviewed scientific publications.
Dr. White went on to receive his Ph.D. from the Ansary Stem Cell Institute, division of Regenerative Medicine at Cornell University under the guidance of Howard Hughes investigator Dr. Shahin Rafii. During this time Dr. White developed an in vitro method for culture expanding autologous HSCs in an artificial vascular niche for the treatment of cancer patients who have undergone bone marrow ablation following chemo- or radio-therapy. This technology has since gone on to be commercialized by Cornell and the company, Angiocrine, LLC, has become one of the top two HSC expansion companies in the US. Following the completion of his Ph.D., Dr. White spent time as a post-doctoral research scientist in the embryonic stem cell (ESC) laboratory of Dr. Stephen Dalton, whose pioneering work led to the inclusion of c-myc as one of the four factors used by Nobel award-winning Dr. Shinya Yamanaka in the generation of induced pluripotent stem cells (iPSCs).
Subsequently, Dr. White relocated to the Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine. Dr. White published ground-breaking research in the field of regenerative medicine alongside Dr. Joshua Hare, including a book chapter on the use of Mesenchymal Stem Cells (MSCs) in cardiac regeneration. In 2015, Dr. White’s work on the regeneration of the heart was featured on the cover of Circulation Research, one of the top peer-reviewed journals for cardiovascular medicine in the world. In 2016. Dr. White was honored with an award for the “Best Manuscript” by the American Heart Association for this work, which highlighted the role of peripheral nerves in cardiac regeneration. Dr. White has lectured and published extensively in the field of stem cell biology, clinical stem cell applications and regenerative medicine.
*Connect With Guest* Website: https://neobiosis.com LinkedIn: www.linkedin.com/in/ian-white-phd
100 bölüm
Paylaş
